missing translation for 'onlineSavingsMsg'
Learn More

SLC45A3/Prostein Antibody (SR1926), Novus Biologicals™

Rabbit Monoclonal Antibody

Brand:  Novus Biologicals NBP3-22464-100ul

 View more versions of this product

Product Code. 18654315

  • 449.00 € / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

SLC45A3/Prostein Monoclonal antibody specifically detects SLC45A3/Prostein in Human samples. It is validated for Western Blot, Immunohistochemistry
TRUSTED_SUSTAINABILITY
Specifications

Specifications

SLC45A3/Prostein
Monoclonal
Unconjugated
PBS, pH 7.4, 150mM NaCl, 50% glycerol.
Rabbit
Affinity purified
RUO
85414
Store at -20° C. Avoid freeze/thaw cycles.
IgG
Western Blot, Immunohistochemistry
SR1926
Western Blot 1:500-1:2000, Immunohistochemistry 1:50-1:200
IPCA-2, IPCA-6, IPCA-8, PCANAP6IPCA6, PCANAP8, prostate cancer associated protein 2, prostate cancer associated protein 6, prostate cancer associated protein 8, prostate cancer-associated gene 2, prostate cancer-associated gene 6, prostate cancer-associated gene 8, Prostate cancer-associated protein 6, Prostein, PRSTPCANAP2, solute carrier family 45 member 3, solute carrier family 45, member 3
A synthesized peptide derived from human SLC45A3/Prostein (Uniprot #: Q96JT2)
100 μg
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.